Rotterdam Criteria Decoded: Navigating the Four Clinical Phenotypes of PCOS

Polycystic Ovary Syndrome (PCOS) is one of the most common endocrine disorders affecting women of reproductive age, impacting approximately 8% to 20% of women worldwide. Despite its high prevalence, PCOS remains a highly heterogeneous condition, meaning that symptoms and severity can vary significantly from one individual to another.

To standardize diagnosis, experts introduced the Rotterdam Criteria for PCOS in 2003. These guidelines revolutionized the understanding of PCOS by recognizing that the syndrome can present in multiple forms rather than as a single disease entity.

Today, the Rotterdam Criteria remain the most widely accepted diagnostic framework worldwide. Understanding these criteria and the four distinct clinical phenotypes can help women receive accurate diagnoses, individualized treatment, and better long-term health outcomes.

What Are the Rotterdam Criteria for PCOS?

The Rotterdam Criteria were established during a joint workshop organized by the European Society of Human Reproduction and Embryology (ESHRE) and the American Society for Reproductive Medicine (ASRM).

According to these guidelines, a diagnosis of PCOS can be made when a woman exhibits at least two of the following three features, after excluding other possible medical conditions:

1. Hyperandrogenism

Hyperandrogenism refers to elevated androgen (male hormone) levels.

It may be:

• Clinical hyperandrogenism, presenting as:

  • Excess facial or body hair (hirsutism)
  • Acne
  • Male-pattern hair loss

• Biochemical hyperandrogenism, confirmed through blood tests showing elevated androgen levels.

2. Ovulatory Dysfunction

Ovulatory dysfunction involves irregular or absent ovulation.

Common manifestations include:

• Irregular menstrual cycles
• Infrequent periods (oligomenorrhea)
• Complete absence of menstruation (amenorrhea)

Women with ovulatory dysfunction often experience fertility challenges.

3. Polycystic Ovarian Morphology (PCOM)

Ultrasound examination may reveal ovaries containing multiple small follicles.

Traditionally, PCOM is characterized by:

• Increased ovarian volume, or
• Presence of numerous small follicles within the ovaries

Importantly, polycystic-appearing ovaries alone do not confirm PCOS.

Why Are the Rotterdam Criteria Important?

Before the Rotterdam Criteria, many women with milder or atypical presentations remained undiagnosed.

The criteria:

• Recognize the diversity of PCOS presentations.
• Improve diagnostic accuracy.
• Facilitate personalized treatment.
• Enable better prediction of metabolic and reproductive risks.
• Support research and clinical standardization.

Based on combinations of the three diagnostic features, four clinical phenotypes have been identified.

---

The Four Clinical Phenotypes of PCOS

Phenotype A: Classic PCOS

Features Present:

✔ Hyperandrogenism
✔ Ovulatory dysfunction
✔ Polycystic ovarian morphology

Phenotype A is considered the classic and most severe form of PCOS.

Common Symptoms

• Irregular or absent periods
• Significant hirsutism
• Persistent acne
• Hair thinning
• Infertility
• Weight gain

Metabolic Risk

Women with Phenotype A often demonstrate:

• Insulin resistance
• Obesity
• Increased risk of Type 2 diabetes
• Metabolic syndrome
• Cardiovascular risk factors

Because both reproductive and metabolic abnormalities are pronounced, these patients frequently require comprehensive management.

---

Phenotype B: Non-Polycystic Ovary Classic PCOS

Features Present:

✔ Hyperandrogenism
✔ Ovulatory dysfunction
✘ No polycystic ovaries on ultrasound

Women with Phenotype B exhibit hormonal and ovulatory abnormalities despite having normal ovarian morphology.

Clinical Characteristics

• Menstrual irregularities
• Elevated androgen levels
• Hirsutism and acne
• Fertility issues

Metabolic Profile

Research suggests that metabolic disturbances in Phenotype B are often comparable to those seen in Phenotype A.

Consequently, women in this category may still experience:

• Insulin resistance
• Obesity
• Dyslipidemia
• Increased diabetes risk

Absence of polycystic ovaries does not necessarily indicate a milder disease.

---

Phenotype C: Ovulatory PCOS

Features Present:

✔ Hyperandrogenism
✘ Ovulatory dysfunction
✔ Polycystic ovarian morphology

Phenotype C is frequently referred to as ovulatory PCOS.

Women continue to ovulate relatively normally and may have regular menstrual cycles.

Typical Presentation

• Acne
• Excess hair growth
• Mild androgen excess
• Normal or near-normal menstrual cycles

Many women remain undiagnosed because regular menstruation can create a false impression of normal reproductive health.

Fertility and Metabolic Risk

Although fertility is generally less affected, subtle ovulatory abnormalities may still occur.

Metabolic disturbances are often milder than in classic PCOS but may still include:

• Insulin resistance
• Central obesity
• Abnormal lipid profiles

Regular follow-up remains important.

---

Phenotype D: Non-Hyperandrogenic PCOS

Features Present:

✘ Hyperandrogenism
✔ Ovulatory dysfunction
✔ Polycystic ovarian morphology

Phenotype D is commonly known as non-hyperandrogenic PCOS.

Unlike other phenotypes, androgen excess is absent.

Common Symptoms

• Irregular periods
• Difficulty conceiving
• Ovulatory dysfunction
• Polycystic ovaries on ultrasound

Women with Phenotype D usually do not exhibit:

• Excess facial hair
• Severe acne
• Significant hair loss

Metabolic Considerations

Phenotype D generally demonstrates the lowest metabolic risk among all phenotypes.

However, some women may still develop:

• Mild insulin resistance
• Weight gain
• Metabolic abnormalities

Therefore, individualized assessment remains essential.

---

Challenges in Diagnosing PCOS

Although the Rotterdam Criteria provide a structured framework, diagnosis still requires exclusion of other medical conditions that can mimic PCOS.

These include:

• Thyroid disorders
• Hyperprolactinemia
• Congenital adrenal hyperplasia
• Cushing syndrome
• Androgen-secreting tumors

A thorough clinical evaluation, laboratory testing, and ultrasound assessment are essential.

How PCOS Phenotypes Influence Treatment

Treatment strategies vary depending on the clinical phenotype, symptoms, and patient goals.

Management may include:

Lifestyle Modifications

• Balanced nutrition
• Regular exercise
• Weight management
• Stress reduction

Medical Therapy

Depending on symptoms, treatment options may involve:

• Combined oral contraceptive pills
• Insulin-sensitizing medications
• Ovulation induction therapies
• Anti-androgen medications

Fertility Management

Women trying to conceive may require:

• Ovulation induction
• Assisted reproductive technologies
• Fertility specialist consultation

A personalized approach offers the best outcomes.

Conclusion

The Rotterdam Criteria for PCOS transformed the understanding of Polycystic Ovary Syndrome by recognizing that PCOS exists across a spectrum of clinical presentations.

The four phenotypes—A, B, C, and D—differ in hormonal profile, ovulatory function, metabolic risk, and fertility implications. Understanding these distinctions enables healthcare professionals to provide more accurate diagnoses and individualized treatment plans.

For women living with PCOS, early diagnosis and phenotype-specific management can significantly improve reproductive health, metabolic well-being, and overall quality of life.